New edaravone tablet tested in healthy volunteers
NCT ID NCT06107205
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new tablet version of the drug edaravone (called TTYP01) in 29 healthy adults. The goal was to see if the tablet works the same as the current injection and oral liquid forms. Participants took each form once, and researchers measured drug levels in the blood to compare safety and how the body processes the medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Early Phase Services
San Antonio, Texas, 78209, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- First human trial launches for experimental PSTB100 drug
- Syringe showdown: does a prefilled device deliver drug as well as a vial?
- Healthy volunteers help unlock the Body's handling of a new drug
- Healthy volunteers test new Drug's body processing
- Autoinjector or syringe? study tests how ADL-018 enters the body
- Healthy men test new oral version of edaravone in first human study